About Contact Us Careers

Transradial Closure Devices Market Size and Forecast, by Product (Band/Strap, Knob, Plate Based), Usage (Disposable Devices, Reusable Devices), Application (Surgical Interventions, Diagnostics), End-user (Hospitals, Ambulatory Surgical Centers, Independent Catheterization Centers, Specialized Clinics) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4346
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT
Festive Special Offer
$4550 $2450

Transradial Closure Devices Market Outlook:

Transradial Closure Devices Market size was valued at USD 320.06 million in 2025 and is expected to reach USD 800.46 million by 2035, expanding at around 9.6% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of transradial closure devices is evaluated at USD 347.71 million.

Transradial-Closure-Devices-Market-scope
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

 The growth of the market is primarily attributed to the escalating cases of cardiovascular diseases (CVDs) caused by unhealthy lifestyle choices, anxiety, stress, and other factors. As per the World Health Organization (WHO), 17.9 million people worldwide die from CVDs each year, accounting for 32% of all mortalities. The high prevalence of heart strokes, heart attacks, coronary heart diseases, and other CVD diseases is anticipated to increase the demand for transradial closure devices for radial artery closure in patients with maximum satisfaction and minimum irritation.

Transradial closure devices are an advanced medical product that is gaining popularity all over the world owing to their ability to provide a more convenient location for safe calibration while minimizing the risks associated and reducing discomfort for the patients. In addition, the increasing demand for minimally invasive and non-invasive medical procedures, along with the rapid technological breakthrough in large-bore vascular closure devices, are other growth factors that are attributed to creating a positive outlook for market expansion in the upcoming years. Also, massive investments in developing advanced medical products and rising expenditure on healthcare infrastructure development, especially in developing economies, are anticipated to drive market growth in the upcoming years.

Key Transradial Closure Devices Market Insights Summary:

  • Regional Highlights:

    • By 2035, North America is projected to command the largest 37% share of the transradial closure devices market, owing to the high prevalence of heart disease, a growing elderly population, and access to advanced healthcare facilities.
    • Europe is anticipated to hold about a 35% share by 2035, supported by rising awareness of cardiovascular health improvements and advancements across hospitals, specialized clinics, and independent catheterization centers.

  • Segment Insights:

    • The independent catheterization centers segment is projected to record a significant share by 2035 in the transradial closure devices market, impelled by the increasing burden of cardiovascular diseases and preference for minimally invasive diagnostic alternatives.
    • The band/strap-based product segment is expected to achieve the highest segment share by 2035, supported by its ease of use, selective radial artery compression capability, and superior patient comfort.

  • Key Growth Trends:

    • Worldwide Spike in Coronary Artery Disease (CAD)
    • Growing Prevalence of Strokes

  • Major Challenges:

    • Inadequate Knowledge of Proper Handling of Devices.
    • High Cost of Transradial Closure Devices

  • Key Players: Medtronic plc, Teleflex Incorporated, Merit Medical Systems, Inc., Abbott Laboratories, Fisher & Paykel Healthcare Corporation Limited, Beijing Demax Medical Technology Co., Ltd., Semler Technologies, Inc., Endocor GmbH, Morris Innovative, Inc., Transluminal Technologies, LLC.

Global Transradial Closure Devices Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 320.06 million
    • 2026 Market Size: USD 347.71 million
    • Projected Market Size: USD 800.46 million by 2035
    • Growth Forecasts: 9.6%

  • Key Regional Dynamics:

    • Largest Region: North America (37% Share by 2035)
    • Fastest Growing Region: South Asia
    • Dominating Countries: United States, Germany, United Kingdom, Japan, China
    • Emerging Countries: India, South Korea, Brazil, Indonesia, Mexico

    • Last updated on : 21 November, 2025

Growth Drivers

  • Worldwide Spike in Coronary Artery Disease (CAD) – Coronary artery disease is one such disease that affects the blood-supplying arteries. It is also referred to as ischemic heart disease (IHD). One or more coronary arteries become blocked or progressively narrow with CAD. The most frequent symptom of this inner condition is angina, which causes chest pain. In most cases, CAD results in a heart attack or other issues such as heart failure or arrhythmia. The surge in the number of people suffering from CAD is expected to escalate the global transradial closure devices market in the forecasted period. It is observed that CAD affected approximately 125 million people (1,658 per 100,000), or approximately 2% of the world's population, until 2020. CAD has claimed the lives of more than 9 million people worldwide. Furthermore, the prevalence of CAD is increasing. The current prevalence rate of 1,658 per 100,000 population is expected to increase to 1,849 by 2030 on a global scale.
  • Growing Prevalence of Strokes – For instance, over 12.4 million new strokes occur each year, with people aged 15 to 48 accounting for more than 16% of all stroke cases in the world.
  • Escalation of Lifestyle Diseases – Owing to their busy lifestyles, people are propelled to eat packaged food and minimize their physical activity. As a result, many diseases such as obesity, thyroid, heart disease, high cholesterol levels, and others, which in turn are anticipated to increase the demand for transradial closure devices in diagnosing and treating such illnesses. It was observed that until 2018, around 78% of the global population was directly affected by lifestyle diseases.
  • Rising Cholesterol Level Among the Global Population – As per the Centers for Disease Control and Prevention (CDC), till 2022, high cholesterol (total blood cholesterol 200 mg/dL) have been affecting approximately 38% of adults in the United States.
  • Worldwide Increasing Healthcare Expenditure - According to data released by the World Bank, global healthcare expenditure increased to 9.83% in 2019 from 9.7% in 2018.

Challenges

  • Inadequate Knowledge of Proper Handling of Devices. Improper handling of transradial closure devices may result in radial artery occlusion. It is the most frequent post-procedural complication of TRA, restricting the use of the same radial artery for future procedures.
  • High Cost of Transradial Closure Devices – The costs of transradial closure devices are considerably high owing to their technology and advanced features. As a result, the population with a middle income is anticipated to push further away from adopting transradial closure devices owing to a lack of funds. This trend is expected to pose a threat to market growth during the assessment period.
  • Insufficiency of Knowledge About the Procedure

Transradial Closure Devices Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

9.6%

Base Year Market Size (2025)

USD 320.06 million

Forecast Year Market Size (2035)

USD 800.46 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Transradial Closure Devices Market Segmentation:

End-user Segment Analysis

The global transradial closure devices market is segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, independent catheterization centers, and specialized clinics. Out of these segments, the independent catheterization centers segment is estimated to significantly grow over the forecast period on the back of rising occurrences of cardiovascular diseases, along with the advancement in the medical imaging and visualization systems, people’s preference for an alternative to surgery, and the advantage of minimally invasive tests and treatments offered by independent catheterization centers. All these, factors are leading people to prefer catheterization centers to treat CVDs-related health issues. For instance, a report of 2022 stated that more than 1,00,000 cardiac catheterization processes are conducted in the United States each year. On the other hand, the hospital segment is also expected to hold a significant share of the market owing to the large patient pool visiting hospitals daily and the surgical procedures occurring in hospital settings. In addition, government support to improve hospital infrastructure along with favorable reimbursement policies propels the population to adopt transradial closure devices from hospitals, thus expanding the segment size. 

Product Segment Analysis

The global transradial closure devices market is also segmented and analyzed for demand and supply by product into band/strap-based, knob-based, and plate-based. Out of these three segments, the band/strap-based segment is attributed to garner the highest segment share by 2035. The easy availability and ease to handle of band/strap-based transradial closure devices are considered to be the major factor in segment growth. Also, band/strap-based transradial closure devices have several advantages, such as the captivity to selectively compress the radial artery to enable blood flow while maintaining patency, the availability of preferred band lengths for an exact fit and enhanced patient comfort, and others, that make it an ideal medical product during surgical procedures.

Our in-depth analysis of the global market includes the following segments:

                By Product
  • Band/Strap Based
  • Knob Based
  • Plate Based

                 By Usage
  • Disposable Devices
  • Reusable Devices

                By Application
  • Surgical Interventions
  • Diagnostics

                By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Catheterization Centers
  • Specialized Clinics
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Transradial Closure Devices Market - Regional Analysis

North American Market Insights

 North America industry is likely to account for largest revenue share of 37% by 2035, driven by high prevalence of heart disease in the region along with the increasing geriatric population, and accessibility of advanced healthcare facilities.According to the Centers for Disease Control and Prevention, cardiovascular disease claims one life in the United States every 34 seconds. Moreover, in 2020, approximately 697,000 people in the United States died from heart disease, accounting for 1 out of every 5 deaths. Also, the rising cases of chronic diseases, along with the increased number of patients diagnosed with cardiovascular diseases are anticipated to increase the utilization rate of transradial closure devices for performing surgeries such as coronary artery bypass grafts during the analysis period. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for the development of advanced vascular closure devices to reduce the pain of patients and eliminate the associated risks, are also anticipated to contribute to the market’s growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical products are also anticipated to boost market growth during the forecast period.

Europe Market Insights

Furthermore, it is anticipated that the transradial closure device market in Europe will rank second, with a proportion of about 35% by the end of 2035. The market is benefiting from developments in key end-use sectors like hospitals, specialty clinics, independent catheterization centers, and others.  According to the WHO, cardiovascular disease is responsible for more than half of all deaths in Europe, and 80 percent of premature heart disease and stroke can be avoided. Additionally, as more people become aware of ways to improve cardiovascular health, there is a huge increase in demand for transradial closure devices.

APAC Market Insights

Additionally, it is anticipated that by the end of 2035, the South Asia area will hold a satisfactory share of the market share among all other regions.  With consistent development in recent years, South Asia has emerged as a viable market for transradial devices. According to the World Health Organization, South Asia's healthcare sector is gradually expanding. Over the course of the forecast period, the South Asian transradial closure devices market is anticipated to grow owing to the growing use of these devices in surgical and diagnostic operations.

Transradial-Closure-Devices-Market-regional
Get Strategic Analysis by Region Now: Request Free Sample PDF

Transradial Closure Devices Market Players:

    • Medtronic plc

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teleflex Incorporated
    • Merit Medical Systems, Inc.
    • Abbott Laboratories
    • Fisher & Paykel Healthcare Corporation Limited
    • Beijing Demax Medical Technology Co., Ltd.
    • Semler Technologies, Inc.
    • Endocor GmbH
    • Morris Innovative, Inc.
    • Transluminal Technologies, LLC 

Recent Developments

  • Medtronic plc announced the completion of the acquisition of Affera, Inc. With this acquisition, the company expands its cardiac ablation portfolio with the first integrated cardiac mapping and navigation platform that encompasses fully integrated diagnostics, focal pulsed fields, and radiofrequency ablation solutions.

  • Teleflex Incorporated stated it has received Health Canada approval for its MANTA Vascular Closure Device - the first commercially available biomechanical closure device specifically designed for large bore femoral arterial access sites

  • Report ID: 4346
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT
Festive Special Offer
$4550 $2450
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of transradial closure devices is evaluated at USD 347.71 million.

The global transradial closure devices market size exceeded USD 320.06 million in 2025 and is set to expand at a CAGR of over 9.6%, surpassing USD 800.46 million revenue by 2035.

By 2035, North America is projected to command the largest 37% share of the transradial closure devices market, owing to the high prevalence of heart disease, a growing elderly population, and access to advanced healthcare facilities.

Key players in the market include Medtronic plc, Teleflex Incorporated, Merit Medical Systems, Inc., Abbott Laboratories, Fisher & Paykel Healthcare Corporation Limited, Beijing Demax Medical Technology Co., Ltd., Semler Technologies, Inc., Endocor GmbH, Morris Innovative, Inc., Transluminal Technologies, LLC.

Transradial Closure Devices Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Buy Now Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos